Future investigations should also include an assessment of the effect of burosumab and initiation of treatment at an earlier age on sagittal and axial plane alignment and limb concordance in children with XLH, as well as genotype-phenotype associations of the PHEX gene in predicting improvement with burosumab treatment. The gene discussed is PHEX; the disease is X-linked hypophosphatemia.